CoChat

Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA1c levels in human pancreatic islets

Open access

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: Although recent studies propose that epigenetic factors influence insulin expression, the regulation of the insulin gene in type 2 diabetic islets is still not fully understood. Here, we examined DNA methylation of the insulin gene promoter in pancreatic islets from patients with type 2 diabetes and non-diabetic human donors and related it to insulin expression, HbA(1c) levels, BMI and age. METHODS: DNA methylation was analysed in 25 CpG sites of the insulin promoter and insulin mRNA expression was analysed using quantitative RT-PCR in pancreatic islets from nine donors with type 2 diabetes and 48 non-diabetic donors. RESULTS: Insulin mRNA expression (p = 0.002), insulin content (p = 0.004) and glucose-stimulated insulin secretion (p = 0.04) were reduced in pancreatic islets from patients with type 2 diabetes compared with non-diabetic donors. Moreover, four CpG sites located 234 bp, 180 and 102 bp upstream and 63 bp downstream of the transcription start site (CpG -234, -180, -102 and +63, respectively), showed increased DNA methylation in type 2 diabetic compared with non-diabetic islets (7.8%, p = 0.03; 7.1%, p = 0.02; 4.4%, p = 0.03 and 9.3%, p = 0.03, respectively). While insulin mRNA expression correlated negatively (p < 1 × 10(-6)), the level of HbA(1c) correlated positively (p ≤ 0.01) with the degree of DNA methylation for CpG -234, -180 and +63. Furthermore, DNA methylation for nine additional CpG sites correlated negatively with insulin mRNA expression (p ≤ 0.01). Also, exposure to hyperglycaemia for 72 h increased insulin promoter DNA methylation in clonal rat beta cells (p = 0.005). CONCLUSIONS/INTERPRETATIONS: This study demonstrates that DNA methylation of the insulin promoter is increased in patients with type 2 diabetes and correlates negatively with insulin gene expression in human pancreatic islets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-010-1967-6

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Insulin mRNA levels, insulin content and glucose-stimulated insulin secretion measured in human pancreatic islets. Pancreatic islets from patients with type 2 diabetes show decreased (a) relative insulin mRNA levels, (b) insulin content and (c) glucose-stimulated insulin secretion, compared with non-diabetic control donors. Results are expressed as mean ± SEM. *p < 0.05 vs control islets. Control, non-diabetic donors; GSIS, glucose-stimulated insulin secretion; T2D, donors with type 2 diabetes
Fig. 1 Insulin mRNA levels, insulin content and glucose-stimulated insulin secretion measured in human pancreatic islets. Pancreatic islets from patients with type 2 diabetes show decreased (a) relative insulin mRNA levels, (b) insulin content and (c) glucose-stimulated insulin secretion, compared with non-diabetic control donors. Results are expressed as mean ± SEM. *p < 0.05 vs control islets. Control, non-diabetic donors; GSIS, glucose-stimulated insulin secretion; T2D, donors with type 2 diabetesCC BY-NC · PubMed Central
Fig. 2 DNA methylation of the insulin promoter. (a) A schematic representation of 2,518 bp of the insulin gene region analysed for DNA methylation. Positions of CpG sites in relation to the TSS are indicated: black circles represent analysed CpG sites, grey circles are not analysed. Putative and previously known transcription factor binding sites that co-localise with a CpG site are indicated. DNA methylation levels in percentage are analysed in (b) human pancreatic islets from 48 controls (white bars) and nine type 2 diabetic patients (black bars) as well as in five blood samples (grey bars; one man and four women, 29–57 years) and (c) beta cells (white bars) and alpha cells (black bars) isolated from pancreatic islets of three human donors. Results are expressed as mean ± SEM, and have not been corrected for multiple testing. † p < 0.05 vs control islets, *p < 0.05 vs control islets. BACH2, basic leucine zipper transcription factor 2; COUP, chicken ovalbumin upstream promoter; HNF4, hepatocyte nuclear factor 4; PDX1, pancreatic and duodenal homeobox 1; ISL1, islet 1; EVX1/2, even-skipped homeobox 1/2; MARE, Maf recognition element; NR2C1/2, nuclear receptor subfamily 2, group C, member 1/2; PTF1, pancreas specific transcription factor, NEUROD1, neurogenic differentiation 1
Fig. 2 DNA methylation of the insulin promoter. (a) A schematic representation of 2,518 bp of the insulin gene region analysed for DNA methylation. Positions of CpG sites in relation to the TSS are indicated: black circles represent analysed CpG sites, grey circles are not analysed. Putative and previously known transcription factor binding sites that co-localise with a CpG site are indicated. DNA methylation levels in percentage are analysed in (b) human pancreatic islets from 48 controls (white bars) and nine type 2 diabetic patients (black bars) as well as in five blood samples (grey bars; one man and four women, 29–57 years) and (c) beta cells (white bars) and alpha cells (black bars) isolated from pancreatic islets of three human donors. Results are expressed as mean ± SEM, and have not been corrected for multiple testing. † p < 0.05 vs control islets, *p < 0.05 vs control islets. BACH2, basic leucine zipper transcription factor 2; COUP, chicken ovalbumin upstream promoter; HNF4, hepatocyte nuclear factor 4; PDX1, pancreatic and duodenal homeobox 1; ISL1, islet 1; EVX1/2, even-skipped homeobox 1/2; MARE, Maf recognition element; NR2C1/2, nuclear receptor subfamily 2, group C, member 1/2; PTF1, pancreas specific transcription factor, NEUROD1, neurogenic differentiation 1CC BY-NC · PubMed Central
Fig. 3 Impact of type 2 diabetes on DNA methylation of the insulin promoter. Pancreatic islets from nine patients with type 2 diabetes show elevated insulin promoter DNA methylation in (a) CpG site −234, (b) CpG site −180, (c) CpG site −102 and (d) CpG site +63, compared with 48 non-diabetic donors. Results are expressed as mean ± SEM and have not been corrected for multiple testing. *p < 0.05. Control, non-diabetic donors; T2D, donors with type 2 diabetes
Fig. 3 Impact of type 2 diabetes on DNA methylation of the insulin promoter. Pancreatic islets from nine patients with type 2 diabetes show elevated insulin promoter DNA methylation in (a) CpG site −234, (b) CpG site −180, (c) CpG site −102 and (d) CpG site +63, compared with 48 non-diabetic donors. Results are expressed as mean ± SEM and have not been corrected for multiple testing. *p < 0.05. Control, non-diabetic donors; T2D, donors with type 2 diabetesCC BY-NC · PubMed Central
Fig. 4 Correlations between the level of insulin mRNA expression and insulin promoter DNA methylation in human pancreatic islets. The relative insulin mRNA expression correlates negatively with insulin promoter DNA methylation at (a) CpG site −234 (ρ = −0.64, p < 1 × 10−6), (b) CpG site −180 (ρ = −0.66, p < 1 × 10−6) and (d) CpG site +63 (ρ = −0.72, p < 1 × 10−6), while borderline significance was established for (c) CpG site −102 (ρ = −0.25, p = 0.065)
Fig. 4 Correlations between the level of insulin mRNA expression and insulin promoter DNA methylation in human pancreatic islets. The relative insulin mRNA expression correlates negatively with insulin promoter DNA methylation at (a) CpG site −234 (ρ = −0.64, p < 1 × 10−6), (b) CpG site −180 (ρ = −0.66, p < 1 × 10−6) and (d) CpG site +63 (ρ = −0.72, p < 1 × 10−6), while borderline significance was established for (c) CpG site −102 (ρ = −0.25, p = 0.065)CC BY-NC · PubMed Central
Fig. 5 Impact of hyperglycaemia on insulin promoter DNA methylation at (a) CpG site −234, (b) CpG site −180, (c) CpG site −102 and (d) CpG site +63. The HbA1c level correlates positively with insulin promoter DNA methylation at (a) CpG site −234 (ρ=0.36, p=0.01), (b) CpG site −180 (ρ=0.42, p=0.004) and (d) CpG site +63 (ρ=0.44, p=0.002), while borderline significance was established for (c) CpG site −102 (ρ=0.28, p=0.056) in human pancreatic islets. (e) Clonal rat beta cells cultured in 16.7 mmol/l glucose showed increased insulin promoter DNA methylation of CpG sites −1,057 and +58 and a significant increase was also seen for the average DNA methylation measured across the studied region compared with beta cells cultured in 11.1 mmol/l glucose. Results are expressed as mean ± SEM. *p < 0.05, **p < 0.01. Black bars, beta cells cultured in 16.7 mmol/l glucose; white bars, beta cells cultured in 11.1 mmol/l glucose
Fig. 5 Impact of hyperglycaemia on insulin promoter DNA methylation at (a) CpG site −234, (b) CpG site −180, (c) CpG site −102 and (d) CpG site +63. The HbA1c level correlates positively with insulin promoter DNA methylation at (a) CpG site −234 (ρ=0.36, p=0.01), (b) CpG site −180 (ρ=0.42, p=0.004) and (d) CpG site +63 (ρ=0.44, p=0.002), while borderline significance was established for (c) CpG site −102 (ρ=0.28, p=0.056) in human pancreatic islets. (e) Clonal rat beta cells cultured in 16.7 mmol/l glucose showed increased insulin promoter DNA methylation of CpG sites −1,057 and +58 and a significant increase was also seen for the average DNA methylation measured across the studied region compared with beta cells cultured in 11.1 mmol/l glucose. Results are expressed as mean ± SEM. *p < 0.05, **p < 0.01. Black bars, beta cells cultured in 16.7 mmol/l glucose; white bars, beta cells cultured in 11.1 mmol/l glucoseCC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 261

Metadata

Authors
Yang, B. T., Dayeh, T. A., Kirkpatrick, C. L., Taneera, J., Kumar, R., Groop, L., Wollheim, C. B., Nitert, M. D., & Ling, C.
Affiliations
Lund University (SE)
Corresponding author
Ling, C.
Venue
Diabetologia
Published
2010-11-23
Volume
54
Issue
2
Pages
360-367
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W1985935160
Cited by
251
References
20
Citations by year
2026: 12 · 2025: 5 · 2024: 18 · 2023: 14 · 2022: 19 · 2021: 16 · 2020: 16 · 2019: 26 · 2018: 14 · 2017: 15 · 2016: 18 · 2015: 22 · 2014: 21 · 2013: 15 · 2012: 15
FWCI
11.49
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Diabetologia (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Knut och Alice Wallenbergs Stiftelse
  • Novo Nordisk
  • Vetenskapsrådet
  • Kungliga Fysiografiska Sällskapet i Lund
  • Malmö Högskola
  • Uppsala Universitet
  • Università di Pisa
  • Region Skåne
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
insulin promoter, DNA methylation, insulin gene expression, type 2 diabetes, pancreatic islets, HbA1c, glucose-stimulated insulin secretion, epigenetics, hyperglycemia, pancreatic beta cells, CpG sites
MeSH terms
Animals, Cell Line, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, DNA Methylation, Insulin-Secreting Cells, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA1c levels in human pancreatic islets. https://app.cochat.ai/papers/10.1007/s00125-010-1967-6
The paper
Yang, B. T., Dayeh, T. A., Kirkpatrick, C. L., Taneera, J., Kumar, R., Groop, L., Wollheim, C. B., Nitert, M. D., & Ling, C. (2011). Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA1c levels in human pancreatic islets. Diabetologia. https://doi.org/10.1007/s00125-010-1967-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.